Stock listing
Nuvectis Pharma, Inc.
Selected listing: NVCT · NASDAQ · USD · US
Nuvectis Pharma, Inc. (NASDAQ:NVCT), Health Technology. Latest release Sep 24, 2026: Nuvectis Announces NXP200 Granted Breakthrough Therapy Designation…
- Ticker
- NASDAQ:NVCT
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. is a public company traded under the ticker NVCT in the American market. Nuvectis focuses on developing innovative therapies for cancer treatment.
Latest news from Nuvectis Pharma, Inc.
Nuvectis Announces NXP200 Granted Breakthrough Therapy Designation in China for BRAF V600-Mutant, Recurrent or Progressive, High-Grade Glioma
September 24, 2026
Nuvectis Pharma To Participate in Upcoming Investor Conferences
September 3, 2026
Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights
August 4, 2026
Correction: (Title Correction) Nuvectis Announces Marketing Approval of Ciprocopan (NXP100) in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
July 22, 2026
Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
July 22, 2026
Research Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. company profile
View the public company page for Nuvectis Pharma, Inc. on 6ix.
Nuvectis Pharma, Inc. news
Read company news and market updates connected to Nuvectis Pharma, Inc..
Nuvectis Pharma, Inc. investor events
Find investor webinars, events, and replay context for Nuvectis Pharma, Inc..